Pelgran Pharma Private Limited, a active private limited company, was established on 12 June 2013 in Hyderabad, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24232TG2013PTC088354. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹2.00 Cr and a paid-up capital of ₹1.59 Cr.
It upholds a compliant status. Its leadership includes Pavani Prasad Undavalli (Director), Purnima Rajesh Alla (Director), Bharatha Lakhsmi Vadlamudi (Director). Past directors included V S R K Prasad, Purnima Rajesh Alla, Srinivasa Reddy Emani. It holds ₹3.24 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at D.No.1-149, Plot No.84/B Phase-I, Ida, Jeedimetla, Hyderabad, Telangana, 500055.
U24232TG2013PTC088354
088354
12 June 2013
₹2.00 Cr
₹1.59 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Pelgran Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Pavani Prasad Undavalli | Director | 12 Jun 2013 | Current |
| Purnima Rajesh Alla | Director | 02 Sep 2019 | Current |
| Bharatha Lakhsmi Vadlamudi | Director | 08 Jun 2020 | Current |
| Laxminarayana Reddy Darakapalli | Director | 01 Apr 2019 | Current |
| Rajesh Alla | Director | 12 Jun 2013 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 03 Jun 2020 | Past |
| Pramod Abcsdd | Director | 23 Apr 2019 | Past |
| Pramod Abcsdd | Director | 05 Jan 2023 | Past |
| Pramod Abcsdd | Additional Director | 31 Dec 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Pelgran Pharma Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 37.1% decrease. The company also saw a substantial fall in profitability, with a 53.65% decrease in profit. The company's net worth observed a substantial decline by a decrease of 281.01%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Pelgran Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹32,400,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Nov 2014 | Andhra Bank | ₹3.24 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Pelgran Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Pelgran Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pelgran Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Pelgran Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
The activity Pelgran Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was completed.
Bharatha Lakhsmi Vadlamudi was appointed as a Director was appointed as a Director on 08 Jun 2020 & has been associated with this company since 5 years 6 months . was recorded as a recent event.
The activity Purnima Rajesh Alla was appointed as a Director was appointed as a Director on 02 Sep 2019 & has been associated with this company since 6 years 3 months . was completed.
The activity Laxminarayana Reddy Darakapalli was appointed as a Director was appointed as a Director on 01 Apr 2019 & has been associated with this company since 6 years 8 months . was completed.
A charge with Andhra Bank amounted to Rs. 3.24 Cr with Charge ID 10539832 was registered on 05 Nov 2014. was recorded as a recent event.
The CIN of Pelgran Pharma Private Limited is U24232TG2013PTC088354.
Pelgran Pharma Private Limited is headquartered at D.No.1-149, Plot No.84/B Phase-I, Ida, Jeedimetla, Hyderabad, Telangana, 500055.
Pelgran Pharma Private Limited was incorporated on 12 June 2013.
The current directors of Pelgran Pharma Private Limited are
The primary industry of Pelgran Pharma Private Limited is Manufacturing.
Pelgran Pharma Private Limited is unlisted.
The authorized capital of Pelgran Pharma Private Limited is ₹2.00 Cr, and the paid-up capital is ₹1.59 Cr.
The compliance status of Pelgran Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX